X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
index medicus (20) 20
male (15) 15
carcinoma, non-small-cell lung - drug therapy (14) 14
female (14) 14
lung neoplasms - drug therapy (14) 14
history (13) 13
lung cancer, non-small cell (13) 13
oncology (13) 13
aged (12) 12
cancer (12) 12
lung cancer (12) 12
middle aged (12) 12
chemotherapy (11) 11
care and treatment (10) 10
carcinoma, non-small-cell lung - mortality (9) 9
lung neoplasms - mortality (9) 9
adult (8) 8
analysis (8) 8
bibliography (8) 8
carcinoma, non-small-cell lung - pathology (8) 8
disease-free survival (8) 8
lung neoplasms - pathology (8) 8
hematology, oncology and palliative medicine (7) 7
lung neoplasms - genetics (7) 7
mutation (7) 7
research (7) 7
therapy (7) 7
treatment outcome (7) 7
antineoplastic agents (6) 6
antineoplastic agents - therapeutic use (6) 6
carcinoma, non-small-cell lung - genetics (6) 6
docetaxel (6) 6
gefitinib (6) 6
manuscripts (6) 6
abridged index medicus (5) 5
aged, 80 and over (5) 5
antimitotic agents (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
cisplatin - administration & dosage (5) 5
growth-factor receptor (5) 5
internal medicine (5) 5
medicine & public health (5) 5
neoplasm staging (5) 5
non-small cell lung cancer (5) 5
oncology, experimental (5) 5
product development (5) 5
respiratory tract diseases (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
biomarkers (4) 4
carboplatin (4) 4
cisplatin (4) 4
gemcitabine (4) 4
historia (4) 4
kaplan-meier estimate (4) 4
kinases (4) 4
lung cancer, small cell (4) 4
nivolumab (4) 4
non-small cell lung carcinoma (4) 4
nsclc (4) 4
proportional hazards models (4) 4
quality of life (4) 4
quinazolines - therapeutic use (4) 4
receptor, epidermal growth factor - antagonists & inhibitors (4) 4
receptor, epidermal growth factor - genetics (4) 4
respiratory system (4) 4
survival (4) 4
time factors (4) 4
1st-line treatment (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal, humanized (3) 3
art (3) 3
biography (3) 3
cancer patients (3) 3
cancer therapies (3) 3
catalogs (3) 3
cetuximab (3) 3
clinical trials (3) 3
diagnosis (3) 3
drug administration schedule (3) 3
drug therapy (3) 3
early works to 1800 (3) 3
epidermal growth factor receptors (3) 3
erlotinib (3) 3
europe (3) 3
fuentes (3) 3
genetic aspects (3) 3
histoire (3) 3
histology (3) 3
illumination of books and manuscripts (3) 3
library (3) 3
medicine, general & internal (3) 3
molecular targeted therapy (3) 3
monoclonal antibodies (3) 3
multicenter (3) 3
neoplasms (3) 3
patient outcomes (3) 3
patients (3) 3
pemetrexed (3) 3
protein-tyrosine kinase (3) 3
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (29) 29
Pontifical Inst. Mediaeval Studies - Library use only (12) 12
UTL at Downsview - May be requested (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Art - Library use only (2) 2
Thomas Fisher Rare Book - Rare Book (2) 2
Victoria University CRRS - Library use only (2) 2
Gerstein Science - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
Music - Reference (1) 1
Music - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Map Collection (1) 1
Robarts - Not Returned (1) 1
Royal Ontario Museum - Reference Desk (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Thomas Fisher Rare Book - Reference (1) 1
Toronto East General Hospital - Reference (1) 1
Trinity College (John W Graham) - Oversize (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Oversize (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (66) 66
French (23) 23
Italian (17) 17
Latin (9) 9
German (5) 5
Spanish (3) 3
Ancient Greek (1) 1
Catalan (1) 1
Dutch (1) 1
High (1) 1
Middle (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10066, pp. 255 - 265
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 247 - 255
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 33 - 42
Summary Background Findings from the phase 3 First-Line ErbituX in lung cancer (FLEX) study showed that the addition of cetuximab to first-line chemotherapy... 
Hematology, Oncology and Palliative Medicine | BREAST-CANCER | BIOMARKERS | GROWTH-FACTOR RECEPTOR | OVEREXPRESSION | ONCOLOGY | PROTEIN EXPRESSION | IN-SITU HYBRIDIZATION | CARCINOMAS | GENE AMPLIFICATION | ESTROGEN-RECEPTOR | III TRIAL | Immunohistochemistry | Lung Neoplasms - drug therapy | Up-Regulation | Prospective Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Patient Selection | Young Adult | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Time Factors | Vinblastine - analogs & derivatives | Aged, 80 and over | Biomarkers, Tumor - metabolism | Brazil | Adult | Female | Biomarkers, Tumor - antagonists & inhibitors | Cetuximab | Odds Ratio | Republic of Korea | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - enzymology | Risk Assessment | Europe | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Survival Rate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Care and treatment | Patient outcomes | Oncology, Experimental | Research | Lung cancer, Non-small cell | Antineoplastic agents | Antimitotic agents | Cancer patients | Chemotherapy | Product development | Tumors | Cancer
Journal Article
by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1525 - 1531
Summary Background Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to increase survival in... 
Internal Medicine | GROWTH-FACTOR RECEPTOR | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | THERAPY | CISPLATIN | COMBINATION | GEMCITABINE | ERLOTINIB | PACLITAXEL | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptor, Epidermal Growth Factor - drug effects | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Young Adult | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Aged, 80 and over | Adult | Female | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Proportional Hazards Models | Survival Rate | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Carcinoma, Non-Small-Cell Lung - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Chemotherapy | Research | Comparative analysis | Lung cancer, Non-small cell | Drug therapy | Health aspects | Cancer | Drugs | Studies | Data analysis | Lung cancer | Acne | Monoclonal antibodies | Clinical medicine | Kinases | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 713 - 721
Journal Article
Journal Article
Seminars in Thoracic and Cardiovascular Surgery, ISSN 1043-0679, 2017
Abstract Objective Following definitive chemo-radiation therapy, 24-35% of patients with locally advanced non-small cell lung cancer have recurrence. We aimed... 
Cardiothoracic Surgery
Journal Article
European Radiology, ISSN 0938-7994, 1/2016, Volume 26, Issue 1, pp. 32 - 42
Journal Article